Free Newsletter
Study: Zoloft, Lexapro beat other antidepressants
Free newsletter via e-mail
Tools
Doctors have long assumed that most antidepressants are interchangeable. But according to a new study, Pfizer's Zoloft and Cipralex/Lexapro, marketed by Forest Laboratories and Lundbeck, work slightly better than 10 other popular drugs, and should be psychiatrists' first choice for patients with moderate to severe depression. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: